MA34100B1 - Compositions d'argile - Google Patents

Compositions d'argile

Info

Publication number
MA34100B1
MA34100B1 MA35267A MA35267A MA34100B1 MA 34100 B1 MA34100 B1 MA 34100B1 MA 35267 A MA35267 A MA 35267A MA 35267 A MA35267 A MA 35267A MA 34100 B1 MA34100 B1 MA 34100B1
Authority
MA
Morocco
Prior art keywords
compositions
semi
clay compositions
solid
active ingredients
Prior art date
Application number
MA35267A
Other languages
Arabic (ar)
English (en)
Inventor
Béatrice Hacher
Didier Kubiak
Jeremiah Harnett
Nathalie Mondoly
Original Assignee
Ipsen Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma Sas filed Critical Ipsen Pharma Sas
Publication of MA34100B1 publication Critical patent/MA34100B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N17/00—Investigating resistance of materials to the weather, to corrosion, or to light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N11/00—Investigating flow properties of materials, e.g. viscosity, plasticity; Analysing materials by determining flow properties
    • G01N11/10—Investigating flow properties of materials, e.g. viscosity, plasticity; Analysing materials by determining flow properties by moving a body within the material
    • G01N11/14—Investigating flow properties of materials, e.g. viscosity, plasticity; Analysing materials by determining flow properties by moving a body within the material by using rotary bodies, e.g. vane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Pathology (AREA)
  • Environmental & Geological Engineering (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Ecology (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des compositions pharmaceutiques liquides ou semi-solides, plus spécifiquement une suspension aqueuse pharmaceutique ou une pâte semi-solide contenant des argiles minérales naturelles comme principes actifs. Ces compositions sont particulièrement utiles pour traiter la diarrhée aiguë et chronique.
MA35267A 2010-04-29 2011-04-29 Compositions d'argile MA34100B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10290225A EP2386289A1 (fr) 2010-04-29 2010-04-29 Compositions d'argile
PCT/IB2011/001452 WO2011135461A2 (fr) 2010-04-29 2011-04-29 Compositions d'argile

Publications (1)

Publication Number Publication Date
MA34100B1 true MA34100B1 (fr) 2013-03-05

Family

ID=43085912

Family Applications (1)

Application Number Title Priority Date Filing Date
MA35267A MA34100B1 (fr) 2010-04-29 2011-04-29 Compositions d'argile

Country Status (22)

Country Link
US (1) US9511023B2 (fr)
EP (3) EP2386289A1 (fr)
JP (2) JP5809244B2 (fr)
KR (1) KR101784032B1 (fr)
CN (2) CN102869342B (fr)
AU (2) AU2011246978B2 (fr)
BR (1) BR112012023532A2 (fr)
CA (1) CA2795613C (fr)
EA (2) EA021301B1 (fr)
ES (1) ES2657707T3 (fr)
HK (1) HK1223565A1 (fr)
HU (1) HUE035714T2 (fr)
JO (1) JO3335B1 (fr)
MA (1) MA34100B1 (fr)
MX (1) MX2012012412A (fr)
PL (1) PL2563332T3 (fr)
PT (1) PT2563332T (fr)
TN (1) TN2012000451A1 (fr)
TR (1) TR201802106T4 (fr)
TW (2) TWI554274B (fr)
UA (1) UA108377C2 (fr)
WO (1) WO2011135461A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8778398B2 (en) 2008-11-04 2014-07-15 Jazz Pharmaceuticals, Inc. Immediate release formulations and dosage forms of gamma-hydroxybutyrate
AU2011232408B2 (en) 2010-03-24 2015-07-30 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
EP2386289A1 (fr) * 2010-04-29 2011-11-16 Ipsen Pharma S.A.S. Compositions d'argile
DK3023093T3 (da) * 2014-11-20 2017-11-06 S I I T S R L -Servizio Int Imballaggi Termosaldanti Medicinsk præparat på basis af diosmectit
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US10506059B2 (en) * 2016-03-18 2019-12-10 Qualcomm Incorporated Signaling of application content packaging and delivery
ITUA20162277A1 (it) * 2016-04-04 2017-10-04 Chemists Res Srl Composizione comprendente diosmectite
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
CN106344618A (zh) * 2016-10-09 2017-01-25 东南大学 用于预防与治疗免疫失调症、肠炎和孤独症的土壤制剂
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
CN106924283A (zh) * 2017-03-29 2017-07-07 成都维恒医药科技有限公司 一种含蒙脱石、药用活性炭的止泻药物组合物及制备方法和用途
CN108721325B (zh) * 2017-04-13 2020-03-06 辽宁大熊制药有限公司 蒙脱石混悬液及其制备方法
CA3115122A1 (fr) 2018-11-19 2020-05-28 Jazz Pharmaceuticals Ireland Limited Formulations de medicament resistant a l'alcool
AU2020231916A1 (en) 2019-03-01 2021-08-05 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL224413A (fr) 1957-01-28
US3141875A (en) 1961-03-15 1964-07-21 Fmc Corp Crystallite aggregates disintegrated in acid medium
JPH064530B2 (ja) * 1985-02-23 1994-01-19 日本化薬株式会社 親水性基剤
GB8512345D0 (en) * 1985-05-15 1985-06-19 Scras Anti-diarrhea compositions
US5770217A (en) * 1997-07-02 1998-06-23 Atlatl, Inc. Dietary supplement for hematological, immune and appetite enhancement
US20010016577A1 (en) * 1998-08-24 2001-08-23 Douglas Joseph Dobrozsi Oral mucoadhesive compositions containing gastrointestinal actives
CN1326745A (zh) * 2000-06-01 2001-12-19 翟永功 蒙脱石为胃肠道药物的成份
EP1536780A1 (fr) * 2002-08-28 2005-06-08 Pharmacia Corporation Composition liquide de tolterodine administree par voie orale
RU2004129624A (ru) * 2003-10-03 2006-03-10 Стрикс Лимитед (Gb) Сосуд для хранения воды
US7744908B2 (en) * 2003-10-28 2010-06-29 Taro Pharmaceuticals U.S.A., Inc. Spill resistant formulations containing clays
US20070031512A1 (en) * 2005-08-03 2007-02-08 Amcol International Corporation Virus-interacting layered phyllosilicates and methods of inactivating viruses
WO2008009618A2 (fr) * 2006-07-17 2008-01-24 Nestec S.A. Denrées alimentaires faibles en matière grasse et en calories, saines et nutritives
FR2912059B1 (fr) * 2007-02-06 2013-04-05 Scras Utilisation d'argiles pour le traitement de la maladie coeliaque
CN101112387B (zh) * 2007-08-06 2011-04-13 南京白敬宇制药有限责任公司 一种治疗非感染性腹泻的蒙脱石混悬液及其制备方法
CN101129326A (zh) * 2007-08-15 2008-02-27 济南康众医药科技开发有限公司 一种蒙脱石混悬剂制备方法
EP2386289A1 (fr) * 2010-04-29 2011-11-16 Ipsen Pharma S.A.S. Compositions d'argile

Also Published As

Publication number Publication date
PL2563332T3 (pl) 2018-04-30
EP3326610A1 (fr) 2018-05-30
JP2013525418A (ja) 2013-06-20
AU2011246978B2 (en) 2016-04-28
AU2016208328B2 (en) 2017-12-21
PT2563332T (pt) 2018-02-08
JO3335B1 (ar) 2019-03-13
KR101784032B1 (ko) 2017-10-10
US9511023B2 (en) 2016-12-06
EA201291125A1 (ru) 2013-04-30
EP2563332B1 (fr) 2017-11-15
UA108377C2 (xx) 2015-04-27
JP5809244B2 (ja) 2015-11-10
AU2011246978A1 (en) 2012-11-22
CA2795613A1 (fr) 2011-11-03
CN102869342A (zh) 2013-01-09
WO2011135461A2 (fr) 2011-11-03
US20130059016A1 (en) 2013-03-07
EP2563332A2 (fr) 2013-03-06
EA201400903A1 (ru) 2014-11-28
TN2012000451A1 (en) 2014-01-30
HUE035714T2 (en) 2018-05-28
CN102869342B (zh) 2016-01-06
KR20130060218A (ko) 2013-06-07
TWI554274B (zh) 2016-10-21
TWI538679B (zh) 2016-06-21
JP2016020373A (ja) 2016-02-04
EP2386289A1 (fr) 2011-11-16
EA026052B1 (ru) 2017-02-28
JP6073998B2 (ja) 2017-02-01
BR112012023532A2 (pt) 2016-07-26
TR201802106T4 (tr) 2018-03-21
TW201141492A (en) 2011-12-01
ES2657707T3 (es) 2018-03-06
MX2012012412A (es) 2012-12-17
AU2016208328A1 (en) 2016-08-11
CN105520954A (zh) 2016-04-27
CA2795613C (fr) 2017-11-21
WO2011135461A3 (fr) 2012-03-01
HK1223565A1 (zh) 2017-08-04
EA021301B1 (ru) 2015-05-29
TW201601733A (zh) 2016-01-16

Similar Documents

Publication Publication Date Title
MA34100B1 (fr) Compositions d'argile
EA200800514A1 (ru) Замещённые 7-азаиндазолы, содержащие их композиции, способ получения и применения
BR112012032028A2 (pt) compostos de tioacetato, composições e métodos de uso.
TW200621745A (en) Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
MA38341A1 (fr) Modulateurs d'enzymes de modification par méthylation, compositions et utilisations associées
MA35920B1 (fr) Composés destinés au traitement de l'amyotrophie spinale
DE602007008851D1 (de) Ektionsmittel
EA200702329A1 (ru) Замещенные пирролпиридины, содержащие их композиции, способ получения и применение
MA37762B1 (fr) Composés n-aryltriazole utilisés comme antagonistes de lpar
MA33044B1 (fr) Composition pharmaceutique contenant des derives de glucopyranosyl diphenylmethane, sa forme posologique galenique, son procede de preparation et ses utilisations pour une regulation glycemique amelioree chez un patient
EA200700035A1 (ru) Сульфаматные и сульфамидные производные для лечения эпилепсии и родственных di sorders
DE602004013563D1 (de) Rantagonisten
EA201170653A1 (ru) Концентрированный шампунь
ZA200707973B (en) Low amounts of high molecular weight polymer for enhancing viscosity of aqueous/aqueous biphasic liquids
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
EA201170652A1 (ru) Композиция
MX2009013536A (es) Una nueva composicion coadyuvante a base de aceite.
EA201690079A1 (ru) Композиция, содержащая глутаминовую-n,n-диуксусную кислоту (glda), воду и фермент
BRPI0821373B8 (pt) composições farmacêuticas contendo ao menos um princípio ativo protéico protegido de enzimas digestivas
ATE472998T1 (de) Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis
EA201391555A1 (ru) Составы суспензионного типа для местного применения, содержащие циклический депсипептид
EA201490704A1 (ru) Композиции антиперспиранта и способ уменьшения потоотделения
MX2009007265A (es) Sales, composiciones liquidas acuosas que cotienen sales de acido s-(+)-abscisico y metodos para su preparacion.
EA201400534A1 (ru) Жидкая противомикробная композиция для очищения твердой поверхности
MX341189B (es) Composicion liquida y acousa de bromfenaco, que tiene efectividad conservadora.